Latest News & Updates

Breaking News

  • 21 hours ago

  • Simantini Singh Deo

CII Appoints Kantipudi and Panicker to Lead CRDMO Task Force for Policy Advocacy
Breaking News
Indian DST Researchers Achieve Targeted Gene-Silencing Nanomedicine Milestone in Breast Cancer Program

Simantini Singh Deo

Other trending news you may like to read

CII Appoints Kantipudi and Panicker to Lead CRDMO Task Force for Policy Advocacy

CII appoints Kantipudi and Panicker to co-lead its CRDMO task force, targeting policy advocacy and global competitiveness for India's contract manufacturing sector.

Simantini Singh Deo

Pharma Now

Indian DST Researchers Achieve Targeted Gene-Silencing Nanomedicine Milestone in Breast Cancer Program

DST-funded Pune researchers report targeted gene-silencing nanomedicine that inhibits breast cancer tumor growth with minimal toxicity, signaling future GMP formulation demands.

Simantini Singh Deo

Pharma Now

FDA Expands State Collaboration Framework for 503A and 503B Compounding Oversight

FDA's state collaboration framework on compounding oversight is expanding, with direct inspection and enforcement implications for 503A and 503B facilities.

Simantini Singh Deo

Pharma Now

Becton Dickinson Issues Class I Correction for BD Spinal Trays After Huons Bupivacaine GMP Failure

Becton Dickinson's Class I correction of BD Spinal Trays, triggered by a GMP failure at bupivacaine supplier Huons Co., Ltd., signals supply chain risk for combination product manufacturers.

Simantini Singh Deo

Pharma Now